Subscribe to RSS
DOI: 10.1055/s-0033-1363976
Synthesis and Antitubercular Activity of Novel 3,5-diaryl-4,5-dihydro-1H-pyrazole Derivatives
Publication History
received 17 November 2013
accepted 16 December 2013
Publication Date:
20 January 2014 (online)

Abstract
Novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives were efficiently synthesized and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv (MTB). The chemical structures of the compound were elucidated by elemental analysis, FTIR, 1H NMR, and mass spectral data. Most of the title compounds have exhibited significant antitubercular activity. Compounds 4g, 4h, 4l, 4n and 4o showed pronounced antitubercular activity comparable to the reference isoniazid, whereas, compounds 4a, 4c, 4j, 4k, and 4p displayed good antitubercular activity. 5-(4-chlorophenyl)-4,5-dihydro-3-p-tolylpyrazol-1-yl-(6-methylimidazo[2,1-b]thiazol-5-yl)methanone (4g) was found to be the most promising compound with MIC values of 0.39 µg/ml.
-
References
- 1 World Health Organization (WHO) Global Tuberculosis Control, ISBN 978 924 1564380
- 2 Villemagne B, Crauste C, Flipo M et al. Tuberculosis: The drug development pipeline at a glance. Eur J Med Chem 2012; 51: 1-16
- 3 World Health Organization (WHO). Anti-t uberculosis drug resistance in the world. Report No. 3. Prevalence and trend s. WHO/HTM/TB /2004
- 4 Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-432
- 5 Nauduri D, Reddy GB. Antibacetrials and Antimycotics: Part 1: Synthesis andActivity of 2-Pyrazoline Derivatives. Chem Pharm Bull (Tokyo) 1998; 46: 1254-1260
- 6 Kucukguzel SG, Rollas S, Erdeni M et al. Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur J Med Chem 2000; 35: 761-771
- 7 Ali MA, Shaharyar M, Siddiqi AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007; 42: 268-275
- 8 Koca I, Ozgur A, Coskun KA et al. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety. Biorg & Med Chem 2013; 21: 3859-3865
- 9 Raeymaekers AHM, Allewijn FTN, Vandenberk J et al. Novel broad-spectrum Anthelmintics.Tetramisol and related derivatives of 6-arylimidazo [2,1-b]thiazole. J Med Pharm Chem 1966; 9: 545-551
- 10 Juspin T, Laget M, Terme T et al. TDAE-assisted synthesis of new imidazo[2,1 b]thiazole derivatives as anti-infectious agents. Eur J Med Chem 2010; 45: 840-845
- 11 Rao YK, Fang SH, Tzeng YM et al. Synthesis and biological evaluation of 3,4,5-trimethoxychalcone analogus as inhibitors of nitric oxide production and tumor proliferation. Biorg & Med Chem 2009; 17: 7909-7914
- 12 Cesur Z, Guner H, Otuk G et al. Synthesis and antimycobacterial activity of new Imidazo [2,1-b]thiazole derivatives. Eur J Med Chem 1994; 29: 981-993
- 13 Messick JB, Berent LM, Cooper SK. Development and Evaluation of a PCR-BasedAssayfor Detection of Haemobartonella felis in Cats and Differentiation of H.felis from Related Bacteria by Restriction Fragment Length Polymorphism Analysis. J Clin Microbiol 1998; 36: 362-366
- 14 Jordao AK, Sathler PC, Ferreira VF et al. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides. Bioorg & Med Chem 2011; 19: 5605-5611
- 15 Gunasekaran P, Perumal S, Yogeeswari P. A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation. Eur J Med Chem 2011; 46: 4530-4536